Overview
Over-the-counter (OTC) drugs are non-prescription, non-legend, drugs sold to consumers by convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.
For the purpose of this study, Kalorama Information has divided products into five general segments:
- Analgesics
- Allergy, Cough, Cold, Flu Remedies
- Gastrointestinal Remedies
- Dermatologics
- Others
(including: Smoking cessation products, Sleepaids, Dental rinses, fluorides, Hair growth remedies, Diet aids)
As part of thorough coverage of the OTC market, this report includes:
Current Market Size and Forecasts by Product Type
- Regional Breakout of Revenues (including Asia Pacific and Africa, Europe, North America, South America regions)
- The Combined Wisdom of over 100 Market Experts interviewed for This Report
- Over 110 Figures and Tables to Make Points in the Text Clear
- Overview of Over the Counter Market
- Review of Successful OTC Products
- Market Share
- Company Profiles
- Discussion of Issues and Trends in OTC
Knowledge of issues affecting the world market for OTC drugs are critical to understanding this market and this report tackles the following issues and trends:
- Consumer Advertising and Promotion
- Demographics
- Prescription vs. OTC Industry
- Rx-to-OTC Switch Industry
- Economic Trends
- Health Insurance Issues and Trends
- Consumer Issues and Trends
- Regulatory Environment
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
The OTC market is vast with many competitors. The following main competitors are profiled in this report:
- Abbott Laboratories
- Novartis
- Wyeth
- Bayer Consumer Health
- Boehringer Ingelheim
- Chattem
- GlaxoSmithKline
- McNeil Consumer (Johnson & Johnson)
- Novartis Pharmaceuticals
- Procter & Gamble
- Reckitt Benckiser
- Sanofi-Aventis
- Schering-Plough
- Taisho Pharmaceutical
- Takeda
- Wyeth Consumer
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Background
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting Market
Leading Competitors
CHAPTER TWO: INTRODUCTION
Background
Distribution and Safety Issues in the United States
Consumer Advertising/Promotion
World Health and Life Expectancy
- Life Expectancy
- Birth Rates
- Tobacco Use
- Obesity
Declining Growth of the World Population
Prescription VS Over-the-Counter Industry
- Rx-to-OTC Switch Industry
- Rx-to-OTC Switch Forecast in the United States
- Economic Trends
- Purchasing Power Trends
- Challenges
Health Insurance Issues and Trends
Consumer Issues and Trends
U.S Consumers
Consumers around the World
Access to Professional Medical Services and the Link to Self-Medication
Regulatory Environment
Revisions to Pharmaceutical Affairs Law (PAL) in Japan
Russian Beneficiary Drug Provision Program
A Third Class of Drugs in the United States
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER FOUR: OTC MARKETS IN EUROPE
Overview
Demographics
OTC Product Segment
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
Overview
Demographics
OTC Product Segments
Market Analysis
OTC Product Segment Market Analysis
Markets by Country
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
Overview
Demographics
OTC Product Segments
Market Analysis
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
Overview
- OTC Product Segment Market Analysis
- Markets by Country
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
Overview
Competitor Analysis
Significant Mergers and Acquisitions
Bristol-Myers Squibb and Novartis AG
Johnson & Johnson and Pfizer
Bayer and Roche
Reckitt Benckiser and Adams Respiratory Therapeutics
Reckitt Benckiser and Boots Healthcare
Leading Corporate Profiles
Bayer Healthcare AG
Boehringer Ingelheim Gmbh
Chattem, Inc.
Glaxo Smith Kline
Mc Neil Consumer (Johnson & Johnson)
Novartis Consumer
Procter & Gamble
Reckitt Benckiser
Sanofi-Aventis
Schering-Plough
Taisho Pharmaceutical
Takeda Pharmaceutical
Wyeth
APPENDIX: LIST OF MAJOR COMPANIES
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Total World OTC Market Analysis, 2005-2007
Table 1-2: Forecasted Total World OTC Market Analysis: 2008-2012
Figure 1-1: Total World OTC Market Analysis: 2005-2012
CHAPTER TWO: INTRODUCTION
Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and Estimated 2006
Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
Table 2-3: Percent of Smokers by Country
Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions
Table 2-4: Percent of Population that is Obese* in 2003, 2004 and Estimated 2005
Table 2-5: World Population 1980 to 2050
Figure 2-3: World Population 1980 to 2050
Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007
Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007
Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2007
Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2007
Table 2-8: Potential Rx-to-OTC Switches, 2008-2013
Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
Table 2-10: Gross National Income Comparison by Country 2000-2005
Figure 2-7: Gross National Income Growth by Country 2000-2005
Table 2-11: National Healthcare Expenditures in the United States 1960-2010
Figure 2-8: Healthcare Spending as a Percent of GDP in the United States
Table 2-12: Health Insurance Trends in the United States 2003-2006
Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session
CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA
Table 3-1: Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Estimated 2007
Table 3-2: Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Projected 2012
Figure 3-1: Population for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012
Table 3-3: Population by Age Group for Africa, Estimated 2007 and 2012
Figure 3-2: Population for Africa, Estimated 2007 and Projected 2012
Table 3-4: Population by Gender for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012
Figure 3-3: Population by Gender for Asia-Pacific, Estimated 2007 and Projected 2012
Table 3-5: Population by Gender for Africa, Estimated 2007 and Projected 2012
Figure 3-4: Population by Gender for Africa, Estimated 2007 and Projected 2012
Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007 and 2012
Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007
Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2012
Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2007
Table 3-9: Forecasted Asia-Pacific/Africa OTC Market Analysis: 2008-2012
Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2012
Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2007
Table 3-11: Forecasted Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2008-2012
Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2012
Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007
Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007
Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007
CHAPTER FOUR: OTC MARKETS IN EUROPE
Table 4-1: Population by Age for the Five Most Populated Countries in Europe, Estimated 2007
Table 4-2: Population by Age for the Five Most Populated Countries in Europe, Projected 2012
Figure 4-1: Population for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012
Table 4-3: Population by Gender for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012
Figure 4-2: Population by Gender for Europe, Estimated 2007 and Projected 2012
Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
Table 4-5: European OTC Market as a Percentage of World Market, 2007 and 2012
Figure 4-3: European OTC Market as a Percentage of World Market, 2007
Figure 4-4: European OTC Market as a Percentage of World Market, 2012
Table 4-6: European OTC Market Analysis, 2005-2007
Table 4-7: Forecasted European OTC Market Analysis: 2008-2012
Figure 4-5: European OTC Market Analysis: 2005-2012
Table 4-8: European OTC Market Analysis by Product Segment, 2005-2007
Table 4-9: Forecasted European OTC Market Analysis by Product Segment, 2008-2012
Figure 4-6: European OTC Market Analysis by Product Segment, 2005-2012
Figure 4-7: European OTC Market Analysis by Product Segment, 2007
Table 4-10: European OTC Market Analysis by Selected Country, 2007
Figure 4-8: European OTC Market Analysis by Selected Country, 2007
CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA
Table 5-1: Population by Age for the Five Most Populated Countries in North America, Estimated 2007
Table 5-2: Population by Age for the Five Most Populated Countries in North America, Projected 2012
Figure 5-1: Population for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012
Table 5-3: Population by Gender for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012
Figure 5-2: Population by Gender for North America, Estimated 2007 and Projected 2012
Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer)
Table 5-5: North American OTC Market as a Percentage of World Market, 2007 and 2012
Figure 5-3: North American OTC Market as a Percentage of WorldMarket, 2007
Figure 5-4: North American OTC Market as a Percentage of World Market, 2012
Table 5-6: North American OTC Market Analysis, 2005-2007
Table 5-7: Forecasted North American OTC Market Analysis: 2008-2012
Figure 5-5: North American OTC Market Analysis: 2005-2012
Table 5-8: North American OTC Market Analysis by Product Segment, 2005-2007
Table 5-9: Forecasted North American OTC Market Analysis by Product Segment, 2008-2012
Figure 5-6: North American OTC Market Analysis by Product Segment, 2005-2012
Figure 5-7: North American OTC Market Analysis by Product Segment, 2007
Table 5-10: North American OTC Market Analysis by Selected Country, 2007
Figure 5-8: North American OTC Market Analysis by Selected Country, 2007
CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA
Table 6-1: Population by Age for the Five Most Populated Countries in South America, Estimated 2007
Table 6-2: Population by Age for the Five Most Populated Countries in South America, Projected 2012
Figure 6-1: Population for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012
Table 6-3:Population by Gender for the Five Most Populated Countries
in South America, Estimated 2007 and Projected 2012
Figure 6-2: Population by Gender for South America, Estimated 2007 and Projected 2012
Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
Table 6-5: South American OTC Market as a Percentage of World Market, 2007 and 2012
Figure 6-3: South American OTC Market as a Percentage of World Market, 2007
Figure 6-4: South American OTC Market as a Percentage of World Market, 2012
Table 6-6: South American OTC Market Analysis, 2005-2007
Table 6-7: Forecasted South American OTC Market Analysis: 2008-2012
Figure 6-5: South American OTC Market Analysis: 2005-2012
Table 6-8: South American OTC Market Analysis by Product Segment, 2005-2007
Table 6-9: Forecasted South American OTC Market Analysis by Product Segment, 2008-2012
Figure 6-6: South American OTC Market Analysis by Product Segment, 2005-2012
Figure 6-7: South American OTC Market Analysis by Product Segment, 2007
Table 6-10: South American OTC Market Analysis by Selected Country, 2007
Figure 6-8: South American OTC Market Analysis by Selected Country, 2007
CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS
Table 7-1: Total World OTC Market Analysis, 2005-2007
Table 7-2: Forecasted Total World OTC Market Analysis: 2008-2012
Figure 7-1: Total World OTC Market Analysis: 2005-2012
Table 7-3: Total World OTC Market Analysis by Product Segment, 2005-2007
Table 7-4: Forecasted Total World OTC Market Analysis by Product Segment, 2008-2012
Figure 7-2: Total World OTC Market Analysis by Product Segment, 2005-2012
Figure 7-3: Total World OTC Market Analysis by Product Segment, 2007
Figure 7-4: Total World OTC Market Analysis by Product Segment, 2012
Table 7-5: Top Ten World OTC Markets by Country, 2007
Figure 7-5: Top Ten World OTC Markets by Country, 2007
CHAPTER EIGHT: LEADING OTC MANUFACTURERS
Table 8-1: Leading Suppliers Shares of the OTC Market and Significant Segments of Participation, 2007
Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007
